U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07056621) titled 'Does Belimumab Modify the Natural History of SLE? A Propensity Scorematched, Real- World, Basket Study' on June 30.
Brief Summary: This will be a combined retrospective and prospective cohort study, that will evaluate the incidence of de novo Systemic Lupus Erythematosus major organ manifestations (defined as BILAG A flares) in patients receiving belimumab (Arm A) and compare it to 2 standard-of-care groups (SoC) (Arm B: patients on SoC; Arm C: patients on SoC followed-up up to May 1st 2014, the first date where belimumab was available in Greece).
We will utilize survival analysis methods (Kaplan-Meier survival curves and Cox regre...